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Minimally invasive cryoablation is often considered for lung tumor patients with high 
surgical risk or inoperable metastatic lung tumors. Cryoablation is a type of thermal per-
cutaneous ablation in which argon and helium gases are delivered via a cryoprobe to in-
duce tissue freezing and necrosis. We report the case of a 23-year-old woman who had 
suffered from multiple pulmonary endometriosis with frequent intermittent hemoptysis 
during menstruation for 6 years prior to her visit. She was treated with cryoablation at our 
hospital, and since her treatment, she has been doing well with no hemoptysis for at least 
6 months. Although endometriosis is a benign lung disease, cryoablation is an ideal and 
effective treatment option for patients with multiple endometriosis.
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Case report
We report the case of a 23-year-old woman who had suf-
fered from intermittent hemoptysis during menstruation 
for 6 years prior to seeking medical care. After receiving 
an initial diagnosis of pulmonary endometriosis at a local 
hospital, the patient reported at our institution wanting a 
complete cure of hemoptysis with eradication of the pul-
monary endometriosis using a minimally invasive surgical 
method. A gynecological examination showed no evidence 
of pelvic endometriosis.
A full check-up, including chest computed tomography 
(CT), was performed at the Department of Thoracic and 
Cardiovascular Surgery of G SAM Hospital. Chest CT 
showed multiple endometrioses in both lungs (Figs. 1, 2A); 
hence, complete eradication of endometriosis was not pos-
sible, even with multiple wedge resections (Fig. 1). As a re-
sult, cryoablation was considered and performed as an ini-
tial treatment to destroy the 2 large endometrial lesions in 
the right lung.
Cryoablation with real-time CT was performed in a ra-
diology intervention room at G SAM Hospital on January 
23, 2019. The cryoablation system involved argon and heli-
um gases used with disposable cryoprobes with 2 sharp 
tips 1.47 mm in diameter (Galil Medical, Yokneam, Israel). 
The patient was placed in the prone position, and the 2 
cryoprobes were inserted into the centers of the endome-
trial lesions in the right lung under local anesthesia using 
Fig. 1. Pre-cryotherapy chest computed tomography scan showing 
multiple endometrioses in the right and left upper lobes, Decem-
ber 2018.
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2.0% lidocaine. Throughout the procedure, the patient’s 
blood pressure, echocardiogram, and oxygen saturation 
were monitored. Freezing and thawing were repeated 3 
times each in accordance with the freeze-thaw protocol. 
The freezing process was conducted using argon gas and 
continued until the temperature of the tip of the cryoprobe 
was −40°C (beginning at −20°C). This process took 3, 7, 
and 10 minutes for the first, second, and third repetitions, 
respectively. The thawing process was conducted using he-
lium gas and continued until the temperature of the tip 
reached 20°C; this took 3 minutes for the first repetition, 5 
minutes for the second, and 2 minutes for the third.
The postoperative course was uneventful, and the patient 
was discharged 3 days after the cryoablation procedure. A 
follow-up chest CT scan was performed 1 day after the 
procedure and showed a large ice-ball shadow, despite the 
complete destruction of the endometrial lesions (Fig. 2B). 
Another follow-up chest CT scan was performed 3 months 
after the cryoablation procedure and showed a marked de-
crease in the size of the ice-ball shadow, suggesting com-
plete eradication of the endometrial lesions (Fig. 2C). The 
patient will undergo regular follow-up at our outpatient 
clinic, and if symptoms of hemoptysis recur, she will be 
treated with another round of cryoablation.
The patient provided written informed consent for the 
publication of the clinical details and images associated 
with her case.
Discussion
Suspicion of pulmonary endometriosis in women is gen-
erally confirmed based on a clinical history of catamenial 
hemoptysis, active bleeding as observed via bronchoscopy, 
and evidence from CT scans. However, in most previously 
reported cases of pulmonary endometriosis, diagnosis was 
based primarily on the patient’s history of periodic hemop-
tysis concurrent with menstruation. Based on these previ-
ous reports, ectopic endometriosis is not always confirmed 
histologically. The pathogenesis of endometriosis is at-
tributed to lymphatic and venous dissemination of the en-
dometrial tissue to distant sites with subsequent implanta-
tion and proliferation. CT f indings associated with 
pulmonary endometriosis can include well-defined opaci-
ties, nodular lesions, thin-wall cavities, or bullous forma-
tions; however, most cases involving hemoptysis exhibit 
transient radiologic densities in the affected part of the 
lung. Pulmonary endometriosis is not correlated with the 
presence of pelvic endometriosis [1]. In the case of our pa-
tient, diagnosis was based on her clinical history and CT 
scan results. CT images taken during her menstrual period 
before cryoablation showed radiographic opacities in mul-
tiple areas.
Cryosurgery was first introduced in the mid-1850s and 
was further advanced throughout the 1960s with the intro-
duction of the automatic apparatus [2]. Cryoablation is a 
percutaneous thermal treatment option that involves the 
use of argon and helium gases to decrease the temperature 
around the tip of the cryoprobe (the Thomson effect), freez-
ing and thawing the tissue to destroy tumor cells [3]. In 
vivo and in vitro experiments have contributed to the un-
derstanding of the mechanisms of injury in various organs, 
such as the skin, liver, kidney, prostate, pancreas, and tra-
chea/bronchus/lung [2]. Relatively non-invasive manage-
ment techniques, including thermal ablation, radiofrequen-
cy, and cryoablation, may be considered in lung tumor 
patients with high surgical risk or inoperable metastatic 
lung cancer [4]. Cryoablation of lung tumors is usually car-
ried out under local anesthesia and conscious sedation 
with chest CT guidance. The freezing-thawing process is 
performed 3 times, in accordance with the freeze-thaw 
protocol. Freezing is carried out 3 times, for several min-
utes per round, until the temperature of the tip of the cryo-
probe reaches −40°C (from −20°C). Thawing usually takes 
several minutes and is carried out until the temperature of 
the tip of the cryoprobe reaches 20°C [5].
Several mechanisms, including protein denaturation, cell 
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Fig. 2. (A) Pre-cryotherapy chest CT 
scan showing a large endometrial 
lesion on the right lower lobe, De-
cember 2018. (B) Post-cryotherapy 
chest CT scan showing a large ice-
ball shadow on the right lower lobe 
1 day after cryotherapy, January 
2019. (C) Post-cryotherapy chest 
CT scan showing a decreased size 
of the endometrial lesion 3 months 
after cryotherapy, April 2019. CT, 
computed tomography.
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destruction via osmotic shifts in extracellular and intracel-
lular water-to-tissue ischemia, and microvascular throm-
bosis, are known to cause cellular injury as a result of 
cryoablation. As the temperature falls into the freezing 
range, ice crystals begin to form in the extracellular spaces, 
causing cell dehydration. As the temperature decreases 
further, ice crystals may form within the cells; this intra-
cellular ice formation, which disrupts cell function, is a se-
rious threat to cell viability. The disruption of organelles 
and cell membranes can lead to cell death. Furthermore, 
vascular stasis and thrombosis following cold injury are 
also well-known mechanisms of cell injury associated with 
cryoablation.
Common complications of cryoablation include cryoab-
lation scars as well as acute phase reactions (such as alveo-
lar hemorrhage, necrotic debris, inflammation, and edema) 
around the target tumor. As such, assessing the response in 
detail after cryoablation is difficult. Compared with the 
previous scan, all ablation zones should be significantly 
enlarged immediately after cryoablation. Following the 
acute phase reactions, all ablation zones should be de-
creased in size by the 30th and 180th days after cryoabla-
tion. Moreover, the shapes of the ablation zones after 
cryoablation can be classified into 5 patterns: consolida-
tion/atelectasis, nodular, stripe, pleural thickening, and 
disappearance.
To date, to the best of our knowledge, cryoablation has 
not been used to treat pulmonary endometriosis; as such, 
we referenced previous cryoablation treatments used for 
benign lung tumors. Percutaneous cryoablation for lung 
tumors can be performed in a minimally invasive manner, 
with very low complication rates. The most common com-
plication of cryoablation is pneumothorax. This complica-
tion occurs in approximately 12% to 62% of patients after 
cryoablation, and among them, approximately 12% require 
chest tube insertion. The occurrence of pneumothorax 
during or after cryoablation is related to the number or 
size (8G to 11G) of the cryoprobes, and the rate of pneu-
mothorax after cryoablation has been shown to decrease 
with the use of thin cryoprobes (17G). Another common 
complication is pleural effusion. Most pleural effusions are 
self-limiting and resolve with conservative management. 
The reported rates of hemoptysis after cryoablation range 
from 0% to 62%, and in most cases, hemoptysis was self- 
limiting and was resolved with conservative management. 
Other known complications after cryoablation include 
cough, skin injuries, frostbite, empyema, arm paresis, tem-
porary aphasia, phrenic nerve palsy, tumor implantation, 
and subcutaneous emphysema, to name a few [6].
Cryoablation is considered to be useful for the eradica-
tion of benign lung tumors; however, complete eradication 
of endometrial lesions with surgery may not be possible in 
cases of multiple variable-sized endometrioses in both 
lungs [6,7]. For curative cryoablation, the margin of the ice 
ball should extend 3 to 10 mm beyond the tumor margins 
[8]. Larger tumors, with a diameter of greater than 3.5 cm, 
are not sufficiently covered by the ice ball. Another prob-
lem with cryoablation is that the ablated area of lung pa-
renchyma around a lung tumor cannot be clearly differen-
tiated from the margin of the ice ball due to the presence 
of equal water content.
However, in cases of pulmonary endometriosis, the actu-
al endometrial lesions are usually less than 3.5 cm in diam-
eter, despite being shown on the pre-cryoablation chest CT 
as having a diameter of greater than 5.0 cm due to hemor-
rhages around the endometrial lesion. In the case of our 
patient, the largest endometrial lesion (including hemor-
rhages) was smaller than 3.5 cm, and we targeted the cen-
ter of the lesion. Cryoablation can be performed repeatedly 
for recurrent pulmonary endometriosis. Therefore, it can 
be a feasible option for patients with multiple recurrent en-
dometrioses who may be unfit for surgery.
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